Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs DMPA for Perimenopausal Bleeding
NCT04710017Completed
- Sponsor
- Assiut University
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in abnormal uterine bleeding (AUB) comparing Tranexamic acid with Medroxyprogesterone acetate (2 arms). Primary endpoint: Number of bleeding days at 6 months. Started Feb 2021; status: completed.
02
Drugs
tranexamic acidmedroxyprogesterone acetate
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT04710017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04710017.